Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
1.255
+0.025 (2.03%)
Nov 5, 2024, 10:57 AM EST - Market open
CNTB Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 69 | 65 | 48 | 273 | - | - | |
| Market Cap Growth | 34.66% | 36.11% | -82.52% | - | - | - | |
| Enterprise Value | -44 | -66 | -143 | -40 | - | - | |
| Last Close Price | 1.20 | 1.18 | 0.87 | 5.15 | - | - | |
| PE Ratio | - | -1.09 | -0.40 | -1.33 | - | - | |
| PB Ratio | 0.60 | 0.64 | 0.30 | 1.00 | - | - | |
| P/FCF Ratio | -3.32 | -1.35 | -0.45 | -3.10 | - | - | |
| P/OCF Ratio | -3.38 | -1.36 | -0.47 | -3.24 | - | - | |
| EV/EBITDA Ratio | 1.38 | 1.02 | 1.23 | 0.42 | - | - | |
| EV/EBIT Ratio | 1.35 | 1.01 | 1.23 | 0.41 | - | - | |
| EV/FCF Ratio | 1.37 | 1.36 | 1.35 | 0.46 | - | - | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -2.02 | -2.16 | |
| Debt / FCF Ratio | -0.01 | -0.01 | 0.00 | 0.00 | -11.38 | -7.05 | |
| Quick Ratio | 11.82 | 4.89 | 9.76 | 15.30 | 27.03 | 12.56 | |
| Current Ratio | 12.04 | 4.99 | 9.97 | 15.30 | 27.81 | 13.24 | |
| Return on Equity (ROE) | -17.92% | -46.03% | -54.96% | -364.72% | - | - | |
| Return on Assets (ROA) | -12.13% | -27.07% | -31.27% | -26.43% | -16.44% | -17.14% | |
| Return on Capital (ROIC) | -13.38% | -31.29% | -33.80% | -27.92% | -17.20% | -17.85% | |
| Earnings Yield | -32.25% | -91.56% | -247.35% | -74.07% | - | - | |
| FCF Yield | -37.99% | -74.21% | -221.87% | -32.28% | - | - | |
| Buyback Yield / Dilution | -0.14% | -0.04% | -5.49% | -205.31% | -1.27% | -36.71% | |
| Total Shareholder Return | -0.14% | -0.04% | -5.49% | -205.31% | -1.27% | -36.71% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.